|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K2039/505 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61K2039/545 | (2013.01) | ||
| C07K 16/2893 | (2013.01) | ||
| C07K2317/24 | (2013.01) | ||
| A61P 15/00 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 37/02 | (2018.01) |
| (11) | Number of the document | 3028718 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15191491.8 |
| Date of filing the European patent application | 2007-09-11 | |
| (97) | Date of publication of the European application | 2016-06-08 |
| (45) | Date of publication and mention of the grant of the patent | 2022-03-23 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 844251 P | 2006-09-13 | US | |
| 06090169 | 2006-09-14 | EP |
| (72) |
SACHSE, Andreas , DE
MARGOLIN, David Harris , US
|
| (73) |
Alcafleu Management GmbH & Co. KG ,
Lilienthalstrasse 4, 12529 Schönefeld OT Waltersdorf,
DE
Genzyme Corporation , 50 Binney Street, Cambridge, MA 02142, US |
| (54) | TREATMENT OF MULTIPLE SCLEROSIS (MS) WITH CAMPATH-1H |
| TREATMENT OF MULTIPLE SCLEROSIS (MS) WITH CAMPATH-1H |